BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16285947)

  • 1. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
    Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
    Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
    Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
    Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
    Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
    Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
    Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
    Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.
    Durkin AJ; Bloomston M; Yeatman TJ; Gilbert-Barness E; Cojita D; Rosemurgy AS; Zervos EE
    J Am Coll Surg; 2004 Nov; 199(5):724-31. PubMed ID: 15501112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression in patients genetically predisposed to pancreatic cancer.
    Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
    J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
    Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
    J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
    Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
    Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
    Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
    Kumari A; Srinivasan R; Vasishta RK; Wig JD
    Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.
    Hassan R; Laszik ZG; Lerner M; Raffeld M; Postier R; Brackett D
    Am J Clin Pathol; 2005 Dec; 124(6):838-45. PubMed ID: 16416732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.